These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
105 related articles for article (PubMed ID: 22839673)
21. Angiotensin-converting enzyme inhibition by perindopril in the treatment of cardiovascular disease. Brugts JJ; Ferrari R; Simoons ML Expert Rev Cardiovasc Ther; 2009 Apr; 7(4):345-60. PubMed ID: 19379059 [TBL] [Abstract][Full Text] [Related]
22. Comparative effectiveness of combination treatment for hypertension in black Africans. Onakpoya I BMJ Evid Based Med; 2020 Jun; 25(3):112. PubMed ID: 31619455 [No Abstract] [Full Text] [Related]
23. Managing hypertension in high-risk patients: lessons and promises from the STRATHE and ADVANCE trials. Waeber B J Hypertens Suppl; 2006 May; 24(3):S19-27. PubMed ID: 16723862 [TBL] [Abstract][Full Text] [Related]
24. Combination therapy in the extended cardiovascular continuum: a focus on perindopril and amlodipine. Borghi C; Morbini M; Cicero AF J Cardiovasc Med (Hagerstown); 2015 May; 16(5):390-9. PubMed ID: 25590639 [TBL] [Abstract][Full Text] [Related]
25. Amlodipine and angiotensin-converting enzyme inhibitor combination versus amlodipine monotherapy in hypertension: a meta-analysis of randomized controlled trials. Lv Y; Zou Z; Chen GM; Jia HX; Zhong J; Fang WW Blood Press Monit; 2010 Aug; 15(4):195-204. PubMed ID: 20512032 [TBL] [Abstract][Full Text] [Related]
26. Renal outcomes with different fixed-dose combination therapies in patients with hypertension at high risk for cardiovascular events (ACCOMPLISH): a prespecified secondary analysis of a randomised controlled trial. Bakris GL; Sarafidis PA; Weir MR; Dahlöf B; Pitt B; Jamerson K; Velazquez EJ; Staikos-Byrne L; Kelly RY; Shi V; Chiang YT; Weber MA; Lancet; 2010 Apr; 375(9721):1173-81. PubMed ID: 20170948 [TBL] [Abstract][Full Text] [Related]
27. [Lipertance® The ASCOT single-pill combination has finally arrived]. Radermecker RP Rev Med Liege; 2017 Sep; 72(9):416-422. PubMed ID: 28892318 [TBL] [Abstract][Full Text] [Related]
28. [Efficiency perindopril at patients with arterial hypertension and obesity]. Nedogoda SV; Lediaeva AA; Chumachok EV; Tsoma VV; Mazina GG; Salasiuk AS Kardiologiia; 2011; 51(11):38-44. PubMed ID: 22117769 [TBL] [Abstract][Full Text] [Related]
29. [Old or new antihypertensives--which are better?]. Schrader J; Kulschewski A MMW Fortschr Med; 2005 Mar; 147(13):36-7, 39-40. PubMed ID: 15832760 [TBL] [Abstract][Full Text] [Related]
30. Blood pressure control and acceptability of perindopril and its fixed dose combinations with amlodipine or indapamide, in younger patients with hypertension. Bansal S; Chauhan DK; Ramesh D; Barmare S; Chakraborty S Indian Heart J; 2014; 66(6):635-9. PubMed ID: 25634398 [TBL] [Abstract][Full Text] [Related]
31. [EFFECTIVENESS OF FIXED COMBINATION OF PERINDOPRILARGININE AND AMLODIPINE FOR THE TREATMENT OF ARTERIAL HYPERTENSION WITH CONCOMITANT CHRONIC CARDIAC INSUFFICIENCY AND SIGNS OF CHRONIC KIDNEY DISEASE]. Kuznetsova TE; Borovkova NY Klin Med (Mosk); 2015; 93(7):62-6. PubMed ID: 26596062 [TBL] [Abstract][Full Text] [Related]
32. Amlodipine/valsartan single-pill combination: a review of its use in the management of hypertension. Frampton JE; Scott LJ Am J Cardiovasc Drugs; 2009; 9(5):309-30. PubMed ID: 19791840 [TBL] [Abstract][Full Text] [Related]
33. Amlodipine besylate/olmesartan medoximil fixed combination for the treatment of hypertension. Chrysant SG Expert Rev Cardiovasc Ther; 2009 Aug; 7(8):887-95. PubMed ID: 19673666 [TBL] [Abstract][Full Text] [Related]
34. I-COMBINE study: assessment of efficacy and safety profile of irbesartan/amlodipine fixed-dose combination therapy compared with amlodipine monotherapy in hypertensive patients uncontrolled with amlodipine 5 mg monotherapy: a multicenter, phase III, prospective, randomized, open-label with blinded-end point evaluation study. Bobrie G; Clin Ther; 2012 Aug; 34(8):1705-19. PubMed ID: 22853848 [TBL] [Abstract][Full Text] [Related]
35. [Perindopril in the treatment of hypertension and cardiovascular diseases: evolution continues with the orodispersible dosage form]. Václavík J Vnitr Lek; 2013 Apr; 59(4):290-4. PubMed ID: 23711055 [TBL] [Abstract][Full Text] [Related]
36. [Comparative efficacy of a fixed combination perindopril/ indapamide in arterial hypertension patients of various sexes and ages]. Linchak RM Kardiologiia; 2010; 50(6):35-40. PubMed ID: 20659025 [No Abstract] [Full Text] [Related]
37. Initial angiotensin-converting enzyme inhibitor/calcium channel blocker combination therapy achieves superior blood pressure control compared with calcium channel blocker monotherapy in patients with stage 2 hypertension. Jamerson KA; Nwose O; Jean-Louis L; Schofield L; Purkayastha D; Baron M Am J Hypertens; 2004 Jun; 17(6):495-501. PubMed ID: 15177521 [TBL] [Abstract][Full Text] [Related]
38. Effects of blood pressure control with perindopril/indapamide on the microcirculation in hypertensive patients. Debbabi H; Bonnin P; Levy BI Am J Hypertens; 2010 Oct; 23(10):1136-43. PubMed ID: 20508624 [TBL] [Abstract][Full Text] [Related]
39. [Combined therapy of arterial hypertension with the fixed combination of perindopril arginine / amlodipine in real clinical practice: the organization and the main results of the program CONSTANTA]. Kobalava ZhD; Kotovskaia IuV; Luk'ianova EA Kardiologiia; 2013; 53(6):25-34. PubMed ID: 23953042 [No Abstract] [Full Text] [Related]
40. [Vascular effects of perindopril arginine and indapamide fixed combination in patients with arterial hypertension]. Protasov KV; Sinkevich DA; Reshina IV; Zhizhko NV; Logovikova SI; Golubeva LV Kardiologiia; 2012; 52(9):8-14. PubMed ID: 23098541 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]